William Blair & Company’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.49K Buy
13,516
+16
+0.1% +$15 ﹤0.01% 1835
2025
Q4
$20.9K Sell
13,500
-2
-0% -$3 ﹤0.01% 1727
2025
Q3
$21.3K Sell
13,502
-234,500
-95% -$408K ﹤0.01% 1713
2025
Q2
$541K Sell
248,002
-2,787
-1% -$6.75K ﹤0.01% 1068
2025
Q1
$685K Sell
250,789
-32,070
-11% -$126K ﹤0.01% 992
2024
Q4
$1.18M Buy
282,859
+9,900
+4% +$37.4K ﹤0.01% 849
2024
Q3
$1.06M Buy
272,959
+2,690
+1% +$11.3K ﹤0.01% 889
2024
Q2
$1.06M Sell
270,269
-2,795
-1% -$12K ﹤0.01% 855
2024
Q1
$1.14M Buy
273,064
+18,501
+7% +$86.9K ﹤0.01% 823
2023
Q4
$1.2M Buy
254,563
+2,712
+1% +$10.6K ﹤0.01% 805
2023
Q3
$786K Buy
251,851
+122,326
+94% +$492K ﹤0.01% 915
2023
Q2
$595K Buy
129,525
+12,020
+10% +$55.2K ﹤0.01% 999
2023
Q1
$582K Hold
117,505
﹤0.01% 989
2022
Q4
$642K Buy
117,505
+2,500
+2% +$15.3K ﹤0.01% 963
2022
Q3
$748K Sell
115,005
-20,685
-15% -$115K ﹤0.01% 913
2022
Q2
$642K Buy
135,690
+108,329
+396% +$534K ﹤0.01% 987
2022
Q1
$191K Sell
27,361
-3,547
-11% -$24.2K ﹤0.01% 1530
2021
Q4
$315K Buy
+30,908
New +$332K ﹤0.01% 1403

Other funds holding MXCT

William Blair & Company's MXCT Position: Q1 2026 in Review

William Blair & Company increased its MaxCyte (MXCT) stake by 0.12% in Q1 2026, buying an estimated $15 and bringing the position to 13,516 shares worth $9.49K. The position accounts for ﹤0.01% of the portfolio, ranked #1835.

William Blair & Company first reported a position in MXCT in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.2M in Q4 2023. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • William Blair & Company held 13,516 shares of MaxCyte worth $9.49K as of Q1 2026.
  • William Blair & Company bought 16 MaxCyte shares in Q1 2026, an estimated $15.
  • MaxCyte made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #1835 holding.
  • William Blair & Company first reported a position in MaxCyte in Q4 2021 and has held it in 18 quarters since.
  • William Blair & Company's MaxCyte position peaked at $1.2M in Q4 2023.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.